Clinical trial
A Study of the Subcutaneous Injection of a Viscous Antibody Solution With…
NCT00435604 · Halozyme Therapeutics, Industry · Completed
Key facts
| NCT number | NCT00435604 |
|---|---|
| Title | A Study of the Subcutaneous Injection of a Viscous Antibody Solution With Recombinant Human Hyaluronidase |
| Official title | Phase I Dose-Ranging Randomized Double-Blinded Controlled Study of the Subcutaneous Injection of a Viscous Antibody Solution With Recombinant Human Hyaluronidase |
| Lead sponsor | Halozyme Therapeutics, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Healthy |
| Intervention type | Drug |
| Interventions | Hylenex |
| Enrollment | 15 |
| Start date | Feb 1, 2007 |
| Completion | May 1, 2007 |
| First posted | Feb 15, 2007 |
| Last update posted | Oct 17, 2011 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: